Search Blog
Categories
November 2013
M T W T F S S
« Oct   Dec »
 123
45678910
11121314151617
18192021222324
252627282930  

Tags

SGOC, UNIS, AEZS and NWBO added to NASDAQ Active Stock Watch List at GSR

admin

By Growing Stock Report

New York, NY – (ACCESSWIRE) – 11/20/2013 – Growing Stock Report initiates its NASDAQ Active Stock Watch List adding SGOCO Group, Ltd. (NASDAQ:SGOC), Unilife Corporation (NASDAQ:UNIS), Aeterna Zentaris Inc. (NASDAQ:AEZS), and Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) 

SGOCO Group, Ltd. (NASDAQ:SGOC) a company that engages in designing and developing LCD/LED monitors, TVs, and other application-specific products for sale primarily to the flat-panel display market in China is currently up (+29.57%) on 2,186,905 shares traded after SGOCO Group, Ltd. announced that it will release its unaudited financial results for the third quarter ended September 30, 2013, today after the U.S. market closes. SGOCO Group, Ltd. (NASDAQ:SGOC) is currently up (+1042.86%) from its recent 52-week low, which has prompted Growing Stock Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll. 

To find out what other Investors are saying about SGOCO Group, Ltd. (NASDAQ:SGOC)

Click Here: http://www.growingstockreport.com/Survey.aspx?stock=SGOC&SubId=AW 

Unilife Corporation (NASDAQ:UNIS) a company that designs, develops, manufactures, and commercializes injectable drug delivery systems in the United States and internationally is currently up (+24.29%) on 2,789,502 shares traded after Unilife Signed Long-Term Supply Agreement with Hikma to Enhance Delivery of Generic Injectables. Unilife Corporation (NASDAQ:UNIS) is currently up (+102.78%) from its recent 52-week low, which has prompted Growing Stock Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll. 

To find out what other Investors are saying about Unilife Corporation (NASDAQ:UNIS)

Click Here: http://www.growingstockreport.com/Survey.aspx?stock=UNIS&SubId=AW 

Aeterna Zentaris Inc. (NASDAQ:AEZS) a specialty biopharmaceutical company that is engaged in developing and commercializing treatments in oncology and endocrinology worldwide is currently down (-36.48%) on 8,060,298 shares traded after Aeterna Zentaris Announced Pricing of US$15.1 Million Public Offering of Common Shares and Warrants. Aeterna Zentaris Inc. (NASDAQ:AEZS) is currently down (-70.72%) from its recent 52-week high, which has prompted Growing Stock Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll. 

To find out what other Investors are saying about Aeterna Zentaris Inc. (NASDAQ:AEZS)

Click Here: http://www.growingstockreport.com/Survey.aspx?stock=AEZS&SubId=AW 

Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) a development stage biotechnology company that engages in discovering, developing, and commercializing immunotherapy products to treat cancers in the United States is currently down (-25.30%) on 3,280,243 shares traded after Northwest Biotherapeutics priced public offering of 4,895,834 units at a $4.80 per unit, resulting in gross proceeds of $23.5 mln. Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) is currently down (-75.7%) from its recent 52-week high, which has prompted Growing Stock Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll. 

To find out what other Investors are saying about Northwest Biotherapeutics, Inc. (NASDAQ:NWBO)

Click Here: http://www.growingstockreport.com/Survey.aspx?stock=NWBO&SubId=AW 

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed. Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.growingstockreport.com/

Disclosure: GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com